Skip to main content

Toronto Maple Leafs Joffrey Lupul is out for the final 24 games of the season with a sports hernia.

Mark Blinch/The Globe and Mail

Two more veteran Toronto Maple Leafs won't be back this season. But they weren't traded away.

The team officially shut down James van Riemsdyk (broken foot) and Joffrey Lupul (sports hernia) for the final 24 games on Thursday, adding to the team's health woes to end the year.

Van Riemsdyk and Lupul are two of seven Leafs on injured reserve, but it was initially hoped they could return to the lineup. Van Riemsdyk's break, however, did not heal as expected, and he remains in a cast and on crutches seven weeks after first being hurt. Lupul, meanwhile, required surgery.

Story continues below advertisement

Strangely enough, the losses are actually a good thing for the last-place Leafs. They give the team increased flexibility heading into Monday's trade deadline as Toronto can now put their combined $9.5-million in salary cap hits on long-term injured reserve and spend that money on incoming contracts.

One of the Leafs key strategies at the deadline will likely be absorbing bad deals from contending teams and getting draft picks or prospects in return.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies